report start new year
report adj ep includ amort
compar opco/street estim underli result solid
unitedhealthcar earn vs consensu outperform
optum roughli line earn follow quarter
maintain recent establish ep guidanc provid
commentari suggest ep due leap day factor
opco/street prior although tweak quarterli estim
rais ep estim price target
overal continu produc strong result would
surpris see insur follow suit result maintain outperform
recap unitedhealthcar gener segment earn margin
bp y-i mcr line consensu
favor develop line prior period meanwhil optum
earn also line driven optumhealth dmg acquisit
expect optumrx revenu growth continu impact
exit profit remain strong
flu impact manag note robust flu season
activ level remain similar level howev sinc mostli
b-strain sever impact busi furthermor
compani note medexpress busi tend perform well high flu
guidanc earn similar normal practic maintain
recent establish ep guidanc expect
earn repres full-year earn due impact leap day
expect repres over/und earn
full-year believ impli ep compar opco/
street prior
medicar advantag outlook remain robust compani reiter
commentari around medicar advantag growth follow annual enrol
period expect total retail growth grow
year-end net slight group loss dual compon
medicar growth particularli robust grow y-i
medicaid busi perform manag note optim around
medicaid outlook given strong progress state partner relat
re-determin look forward compani also posit rfp
outlook secur wa tx ne expans nc start date
delay indefinit ky re-bid could act driver
year price histori
broad rang product corpor
custom individu
analyst certif import disclosur see disclosur
enrol gain track line compani expect
major chang regul
enrol gain track ahead compani expect
believ well posit virtu diversif
strong track record elit manag team exposur
certain higher growth busi compani optum
busi nice complement core manag care
oper continu account larg share earn
furthermor vertic integr strategi strengthen
compani competit posit across mani area
healthcar landscap result rate share
updat open enrollment/r process
adjust annual guidanc
meaning uptick util trend
price target base combin two methodolog dcf valuat base beta
termin growth rate wacc estim ebitda price-to-earnings target repres
cash ep estim conserv discount manag care industri five-year averag multipl
healthcar polici discuss lawmak continu discuss chang healthcar polici earn could impact
state medicaid budget cut state regularli review reimburs polici could affect earn outlook
medicar reimburs medicar advantag rate risk chang congress
integr risk highli acquisit compani need continu success integr transact
trend would experi impact earn outlook medic cost chang
product sold
total revenu
depreci amort
invest incom
incom tax
net incom report
dilut ep report
amor net tax
sell gener
depreci amort
incom tax
